<DOC>
	<DOCNO>NCT01322282</DOCNO>
	<brief_summary>This study design assess bioequivalence two product use treatment allergy .</brief_summary>
	<brief_title>To Test Bioequivalence Between Two Tablet Formulations Treatment Allergy</brief_title>
	<detailed_description>This study design evaluate test formulation cetirizine 10 mg orodispersible tablet ( ODT ) take without water bioequivalent market reference formulation cetirizine 10 mg tablet ( Benadryl One A Day , McNeil Products Ltd , UK ) take water . This study also evaluate tolerability test reference formulation .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Male female subject Volunteers age least 18 year old 55 year Subjects Body Mass Index ( BMI ) great equal 18.50 30.00 kg/m2 Non exsmokers ; exsmoker define someone completely stop smoke least 12 month day 1 study Clinical laboratory value within laboratory 's state normal range ; within range , must without clinical significance Have clinically significant disease capture medical history evidence clinically significant finding physical examination and/or clinical laboratory evaluation ( hematology , biochemistry , ECG urinalysis ) Has sign date informed consent document , indicate subject inform pertinent aspect study Willingness ability comply schedule visit , treatment plan , laboratory test , study procedure Seated pulse rate 45 bpm high 90 bpm screen Seated blood pressure 90/60 mmHg high 140/90 mmHg screen Relationship person involve directly conduct study ( i.e. , principal investigator ; subinvestigators ; study coordinator ; study personnel ; employee contractor sponsor Johnson &amp; Johnson subsidiary ; family ) Presence tongue piercings Presence brace Females pregnant lactate Females childbearing potential male female partner childbearing potential refuse use acceptable contraceptive regimen throughout entire duration study Females pregnant accord positive serum pregnancy test Any medical history condition , use drug medication , investigator determines could compromise subject safety evaluation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>